koppula jayanthi

@52125010

Pharmaceutical chemistry
SRI BALJI VIDYPEETH

I am Dr Jayanthi, an Associate Professor with a PhD in Pharmaceutical Chemistry. I have over 10 years of teaching and research experience, with expertise in synthetic chemistry and in silico studies. My research primarily focuses on antimicrobial and anticancer drug development, CNS disorders, and computational drug design. I have published more than 11 Scopus-indexed research papers. I have presented my work at several national and international scientific conferences. I am deeply passionate about advancing in pharmaceutical research and mentoring young of Expertise: Synthesis of Pharmaceutical Compounds, in silico studies, Molecular Dynamic Simulation, Microbiology, and Critical Literature Review.
Research Interests: Antimicrobial Agents, Cancer Therapeutics, Central Nervous System (CNS) Disorders, Diabetes,

RESEARCH, TEACHING, or OTHER INTERESTS

Drug Discovery, Pharmaceutical Science, General Pharmacology, Toxicology and Pharmaceutics, Pharmacology, Toxicology and Pharmaceutics
55

Scholar Citations

4

Scholar h-index

2

Scholar i10-index

RECENT SCHOLAR PUBLICATIONS

  • Design and Synthesis of Benzylidene Phenylacetamide-based Derivatives as Potential Antibacterial Agents Targeting Staphylococcus Aureus Thymidylate Kinase
    A BAQI, K JAYANTHI, M MUTHUKUMARAN
    2026
  • DESIGN AND IN SILICO EVALUATION OF PHENOXY ACETAMIDE DERIVATIVES AS POTENTIAL ANTIDIABETIC AGENTS
    S INDHUMATHI, SS NITHI, MAB GOBIANANTH, N VENKATHESHAN, ...
    Int J App Pharm 17 (5), 159-167 , 2025
    2025
  • Molecular docking insights into probiotics SAKACIN P and SAKACIN a as potential inhibitors of the COX-2 pathway for colon cancer therapy
    MA Baqi, K Jayanthi, R Rajeshkumar
    Int J App Pharm 17 (1), 153-160 , 2025
    2025
    Citations: 4
  • Oral delivery of solid lipid nanoparticles surface decorated with hyaluronic acid and bovine serum albumin: a novel approach to treat colon cancer through active targeting
    SS Ahmed, MZ Baba, U Wahedi, J Koppula, MV Reddy, D Selvaraj, ...
    International journal of biological macromolecules 279, 135487 , 2024
    2024
    Citations: 20
  • MOLECULAR DOCKING INSIGHTS INTO PROBIOTICS SAKACIN P AND SAKACIN A AS POTENTIAL INHIBITORS OF THE COX-2 PATHWAY FOR COLON CANCER THERAPY,
    abdul baqi koppula jayanthi
    International Journal of Applied Pharmaceutics 16 (4), 250-6 , 2024
    2024
  • Molecular docking insights into probiotics as potential inhibitors of the P13K pathway for colon cancer therapy
    abdul baqi koppula jayanthi
    International Journal of Applied Pharmaceutics 16 (4), 265-7 , 2024
    2024
  • Identification of Benzylidene Amino Phenol Inhibitors Targeting Thymidylate Kinase for colon cancer Treatment Through in-silico Studies
    abdul baqi koppula jayanthi
    International Journal of Applied Pharmaceutics 16 (4), 292-7 , 2024
    2024
  • Design for the Colon Cancer inhibitors targeting thymidylate kinase using in-silico studies
    abdul baqi koppula jayanthi
    International Journal of Applied Pharmaceutics 16 (3), 292-7 , 2024
    2024
  • Investigation of Scutellaria baicalensis for potential neuroprotective effect on the treatment of Parkinson’s disease,
    koppula jayanthi
    Journal of bio interface research in applied chemistry 14 (2), 250-6 , 2024
    2024
  • Investigation of Scutellaria baicalensis for potential neuroprotective effect on the treatment of Parkinson’s Disease
    MZ Baba, G Subramanian, J Chand, U Wahedi, V Potlapati, K Jayanthi, ...
    Biointerface Res. Appl. Chem 14 (27), 10.33263 , 2024
    2024
    Citations: 7
  • Investigation of Scutellaria baicalensis for Potential Neuroprotective Effect on the Treatment of Parkinson’s
    MZ Baba, G Subramanian, J Chand, U Wahedi, P Varakumar, K Jayanthi, ...
    2024
  • Molecular docking dynamics of selected benzylidene amino phenyl acetamides as TMK inhibitors using high throughput virtual screening (HTVS)
    K Jayanthi, SS Ahmed, MA Baqi, M Afzal Azam
    Int J App Pharm 16 (3), 290-7 , 2024
    2024
    Citations: 4
  • Thymidylate kinase inhibitors as antibacterial agents: A review
    K Jayanthi, MA Azam
    Applied Biochemistry and Microbiology 59 (3), 250-266 , 2023
    2023
    Citations: 20
  • Comparative binding pattern analysis of 5-MeO-DMT and 7-Meo-DMT against 5HT2A receptor employing molecular docking, MMGB-SA, and molecular dynamics studies,
    koppula jayanthi
    Eur. Chem. Bull 12 (5), 250-5 , 2023
    2023

MOST CITED SCHOLAR PUBLICATIONS

  • Oral delivery of solid lipid nanoparticles surface decorated with hyaluronic acid and bovine serum albumin: a novel approach to treat colon cancer through active targeting
    SS Ahmed, MZ Baba, U Wahedi, J Koppula, MV Reddy, D Selvaraj, ...
    International journal of biological macromolecules 279, 135487 , 2024
    2024
    Citations: 20
  • Thymidylate kinase inhibitors as antibacterial agents: A review
    K Jayanthi, MA Azam
    Applied Biochemistry and Microbiology 59 (3), 250-266 , 2023
    2023
    Citations: 20
  • Investigation of Scutellaria baicalensis for potential neuroprotective effect on the treatment of Parkinson’s Disease
    MZ Baba, G Subramanian, J Chand, U Wahedi, V Potlapati, K Jayanthi, ...
    Biointerface Res. Appl. Chem 14 (27), 10.33263 , 2024
    2024
    Citations: 7
  • Molecular docking insights into probiotics SAKACIN P and SAKACIN a as potential inhibitors of the COX-2 pathway for colon cancer therapy
    MA Baqi, K Jayanthi, R Rajeshkumar
    Int J App Pharm 17 (1), 153-160 , 2025
    2025
    Citations: 4
  • Molecular docking dynamics of selected benzylidene amino phenyl acetamides as TMK inhibitors using high throughput virtual screening (HTVS)
    K Jayanthi, SS Ahmed, MA Baqi, M Afzal Azam
    Int J App Pharm 16 (3), 290-7 , 2024
    2024
    Citations: 4
  • Design and Synthesis of Benzylidene Phenylacetamide-based Derivatives as Potential Antibacterial Agents Targeting Staphylococcus Aureus Thymidylate Kinase
    A BAQI, K JAYANTHI, M MUTHUKUMARAN
    2026
  • DESIGN AND IN SILICO EVALUATION OF PHENOXY ACETAMIDE DERIVATIVES AS POTENTIAL ANTIDIABETIC AGENTS
    S INDHUMATHI, SS NITHI, MAB GOBIANANTH, N VENKATHESHAN, ...
    Int J App Pharm 17 (5), 159-167 , 2025
    2025
  • MOLECULAR DOCKING INSIGHTS INTO PROBIOTICS SAKACIN P AND SAKACIN A AS POTENTIAL INHIBITORS OF THE COX-2 PATHWAY FOR COLON CANCER THERAPY,
    abdul baqi koppula jayanthi
    International Journal of Applied Pharmaceutics 16 (4), 250-6 , 2024
    2024
  • Molecular docking insights into probiotics as potential inhibitors of the P13K pathway for colon cancer therapy
    abdul baqi koppula jayanthi
    International Journal of Applied Pharmaceutics 16 (4), 265-7 , 2024
    2024
  • Identification of Benzylidene Amino Phenol Inhibitors Targeting Thymidylate Kinase for colon cancer Treatment Through in-silico Studies
    abdul baqi koppula jayanthi
    International Journal of Applied Pharmaceutics 16 (4), 292-7 , 2024
    2024
  • Design for the Colon Cancer inhibitors targeting thymidylate kinase using in-silico studies
    abdul baqi koppula jayanthi
    International Journal of Applied Pharmaceutics 16 (3), 292-7 , 2024
    2024
  • Investigation of Scutellaria baicalensis for potential neuroprotective effect on the treatment of Parkinson’s disease,
    koppula jayanthi
    Journal of bio interface research in applied chemistry 14 (2), 250-6 , 2024
    2024
  • Investigation of Scutellaria baicalensis for Potential Neuroprotective Effect on the Treatment of Parkinson’s
    MZ Baba, G Subramanian, J Chand, U Wahedi, P Varakumar, K Jayanthi, ...
    2024
  • Comparative binding pattern analysis of 5-MeO-DMT and 7-Meo-DMT against 5HT2A receptor employing molecular docking, MMGB-SA, and molecular dynamics studies,
    koppula jayanthi
    Eur. Chem. Bull 12 (5), 250-5 , 2023
    2023